Cargando…
Antiviral Drugs for EBV
Epstein–Barr virus (EBV) infects up to 95% of the adult human population, with primary infection typically occurring during childhood and usually asymptomatic. However, EBV can cause infectious mononucleosis in approximately 35–50% cases when infection occurs during adolescence and early adulthood....
Autores principales: | Pagano, Joseph S., Whitehurst, Christopher B., Andrei, Graciela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025560/ https://www.ncbi.nlm.nih.gov/pubmed/29899236 http://dx.doi.org/10.3390/cancers10060197 |
Ejemplares similares
-
Involvement of age-associated B cells in EBV-triggered autoimmunity
por: Sachinidis, Athanasios, et al.
Publicado: (2022) -
Viral Infection and Autophagy Dysregulation: The Case of HHV-6, EBV and KSHV
por: Romeo, Maria Anele, et al.
Publicado: (2020) -
Antiviral Drug Discovery To Address the COVID-19 Pandemic
por: Richman, Douglas D.
Publicado: (2020) -
Interpreting the Epstein-Barr Virus (EBV) Epigenome Using High-Throughput Data
por: Arvey, Aaron, et al.
Publicado: (2013) -
SARS-CoV-2 and EBV; the cost of a second mitochondrial “whammy”?
por: Nunn, Alistair V.W., et al.
Publicado: (2021)